| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2204 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1647 | 2018 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 574 | 2014 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 465 | 2022 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 419 | 2014 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 279 | 2014 |
| Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-α2b: a randomized trial DM Jensen, P Marcellin, B Freilich, P Andreone, A Di Bisceglie, ... Annals of internal medicine 150 (8), 528-540, 2009 | 267 | 2009 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 169 | 2023 |
| Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C J Bruix, T Poynard, M Colombo, E Schiff, K Burak, EJL Heathcote, T Berg, ... Gastroenterology 140 (7), 1990-1999, 2011 | 147 | 2011 |
| Disease burden of chronic hepatitis C in Brazil PRA Ferreira, CE Brandão-Mello, C Estes, FL Gonçales, HSM Coelho, ... Brazilian Journal of Infectious Diseases 19 (4), 363-368, 2015 | 100 | 2015 |
| Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study AJ de Almeida, M Campos-de-Magalhães, OP de Melo Marçal, ... Annals of hematology 83, 434-440, 2004 | 93 | 2004 |
| Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study S Vermeire, PL Lakatos, T Ritter, S Hanauer, B Bressler, R Khanna, ... The Lancet Gastroenterology & Hepatology 7 (1), 28-37, 2022 | 69 | 2022 |
| Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy MG Pessôa, B Gazzard, AK Huang, CE Brandão-Mello, I Cassetti, ... Aids 22 (14), 1779-1787, 2008 | 69 | 2008 |
| The case for simplifying and using absolute targets for viral hepatitis elimination goals Polaris Observatory Collaborators, H Razavi, S Blach, D Razavi-Shearer, ... Journal of viral hepatitis 28 (1), 12-19, 2021 | 49 | 2021 |
| Applying landmarks to enhance memory-based collaborative filtering GR Lima, CE Mello, A Lyra, G Zimbrao Information Sciences 513, 412-428, 2020 | 47 | 2020 |
| Entecavir in HIV/HBV co-infected patients: safety and efficacy in a phase II study (ETV-038) W Pessoa, B Gazzard, A Huang, C Brandao-Mello, L Cassetti, M Correa, ... 12th conference on retroviruses and opportunistic infections, 22-25, 2005 | 45 | 2005 |
| Patients with hepatitis C infection and normal liver function: an evaluation of cognitive function J Abrantes, DS Torres, CEB de Mello Postgraduate Medical Journal 89 (1054), 433-439, 2013 | 40 | 2013 |
| Pegintron maintenance therapy in cirrhotic (Metavir F4) HCV patients, who failed to respond to interferon/ribavirin (IR) therapy: final results of the EPIC3 cirrhosis … J Bruix, T Poynard, M Colombo, E Schiff, J Reichen, K Burak, ... Journal of Hepatology 50 (Suppl 1), S22-S22, 2009 | 40 | 2009 |
| Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV-and high-HBV/HDV-prevalence countries HA Razavi, M Buti, NA Terrault, S Zeuzem, C Yurdaydin, J Tanaka, ... Journal of Hepatology 79 (2), 576-580, 2023 | 39 | 2023 |
| Transforming collaborative filtering into supervised learning F Braida, CE Mello, MB Pasinato, G Zimbrão Expert Systems with Applications 42 (10), 4733-4742, 2015 | 39 | 2015 |
